Kristin Yarema
Chief Executive Officer at POSEIDA THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Kristin Yarema is currently the President, Chief Executive Officer & Director at Poseida Therapeutics, Inc. She is also a Director at the Alliance for Regenerative Medicine and the Celiac Disease Foundation.
Previously, she held the position of Vice President at Amgen, Inc. from 2013 to 2020 and served as the Chief Commercial Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2020 to 2022.
Dr. Yarema completed her undergraduate degree at Stanford University and obtained a doctorate from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-01 | 606,836 ( 0.63% ) | 2 M $ | 2024-03-30 |
Kristin Yarema active positions
| Companies | Position | Start |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Chief Executive Officer | 2023-12-31 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 2020-12-31 |
| Celiac Disease Foundation | Director/Board Member | 2016-12-31 |
Former positions of Kristin Yarema
| Companies | Position | End |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 2022-11-14 |
| AMGEN INC. | Corporate Officer/Principal | 2019-12-31 |
Training of Kristin Yarema
| Stanford University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
| Celiac Disease Foundation |
- Stock Market
- Insiders
- Kristin Yarema
